This article has Open Peer Review reports available.
Primary cervical spine carcinoid tumor in a woman with arm paresthesias and weakness: a case report
© Narayanan et al.; licensee BioMed Central Ltd. 2013
Received: 17 March 2013
Accepted: 4 July 2013
Published: 23 August 2013
Carcinoid tumors are neuroendocrine neoplasms derived from the enterochromaffin cells. Central nervous system involvement is rare and has been reported either as metastases to the brain and spine or primary tumors involving the sacrococcygeal spine. We report the first case of a primary carcinoid tumor of the cervical spine.
A 50-year-old African-American woman presented with a 4-month history of numbness, paresthesias, and mild left-hand weakness. Magnetic resonance imaging of her cervical spine revealed a homogenously enhancing extradural mass, indenting the cervical cord and expanding the left neural foramen at C7–T1. A C7 corpectomy, en bloc resection of the tumor, and anterior C6–T1 fusion were performed to decompress the spinal cord and nerves and provide stability. Postoperative histopathologic examination and immunohistochemical analysis were consistent with carcinoid tumor. There has been no recurrence at the 6-year follow-up visit.
Primary cervical carcinoid tumor is extremely rare, but should be included in the differential diagnosis of enhancing expansile extradural masses compressing the spinal cord and nerves. Surgical resection may provide a definitive cure.
Carcinoids are the most common neuroendocrine tumors, deriving from the enterochromaffin cells of the gut and bronchi. Originally believed to behave in a benign fashion, analysis of a large group of patients showed a 67.2% 5-year survival and a 12.9% incidence of metastases at the time of diagnosis. Central nervous system metastases are infrequent and involve either the brain or the spinal column[4–9]. Primary carcinoid tumors of the spine are extremely rare and have been described in the sacrum[10, 11] and coccyx. We report the first case, to the best of our knowledge, of a primary carcinoid tumor in the cervical spine.
A 50-year-old African-American woman presented with a 4-month history of pain, paresthesias, and mild weakness in her left upper extremity. Her past medical history was significant for hypertension and borderline diabetes mellitus. Her family history was positive for breast cancer (sister), prostate cancer (father), and ovarian cancer (two paternal aunts). The patient had a five-pack-year history of smoking cigarettes, but had stopped smoking 7 years prior to presentation. Her review of systems was negative for any hormonal imbalance. A neurological examination revealed hypesthesia and mild weakness in her left C8 spinal nerve distribution, as well as mild hyperreflexia and a Babinski’s sign in the left lower extremity. Preoperative laboratory tests (including complete blood count, complete metabolic panel, and coagulation studies) showed borderline anemia, hypokalemia, and hypoalbuminemia (all asymptomatic).
Under general anesthesia, a standard anterior cervical approach exposed the C6 and C7 discs, along with the adjacent C5 and T1 vertebral bodies. A C6–7 and C7–T1 discectomy was followed by a C7 corpectomy, started slightly right of the midline and extended laterally to the left. The tumor was contiguous with the bone, but much softer, and it compressed the dura mater, but without any obvious invasion and with a clear separating plane. Frozen section pathologic analysis yielded a preliminary diagnosis of metastatic undifferentiated small cell carcinoma, with probable origin from the lung. A gross total resection of the tumor was performed. Due to the extensive and destabilizing bony removal necessary for tumor resection, a C6–T1 instrumented fixation was deemed necessary and performed in a standard fashion. The patient tolerated the procedure without complications.
Carcinoid tumors arise from enterochromaffin cells and have an incidence of 0.28 to 0.8 per 100,000 per year. When hormonally active, these tumors induce the carcinoid syndrome, characterized by flushing, diarrhea, vasodilation, bronchoconstriction, and other symptoms of increased serotonin release. More often, spinal carcinoid tumors manifest by mass effect: myelopathy and/or radiculopathy[6–8, 13–15]. The histopathological appearance is that of a neuroendocrine tumor, with nests and trabeculae of cells exhibiting round or oval nuclei and rare mitoses. The definitive diagnosis is based on positive immunohistochemical staining for chromogranin A and synaptophysin.
There have been several reports of carcinoid metastases to the cervical spine. A 51-year-old man with a history of gastric carcinoid and multiple endocrine neoplasias presented with symptoms of myelopathy, and a cervical MRI revealed an osteoblastic tumor arising from the posterior arch of C2, compressing the spinal cord. The authors performed a surgical removal of the tumor, followed by radiation. Another young patient with known intestinal carcinoid tumor presented with neck pain and was diagnosed with an osteolytic lesion in the left lateral mass of C1, threatening to erode into the vertebral canal. The authors described an elegant CT-guided vertebroplasty treatment of the lesion, with complete resolution of symptoms.
Our patient presented with similar symptoms of myelopathy and radiculopathy. The MRI confirmed the presence of an extradural tumor compressing the spinal cord and left C7 spinal nerve. However, there was no clinical or radiological evidence of a primary tumor that would make metastasis likely, and there were no signs of hormonal imbalance to suggest a neuroendocrine tumor. Therefore, the surgical intervention was started with a wide differential diagnosis in mind and with the decision of total versus partial resection to be made based on intraoperative findings, that is, the amount of tumor involvement with the neural elements. Because the tumor could be relatively easily separated from the dura of the spinal cord and nerve, we performed a gross total resection, at the cost of removing a large portion of the C7 vertebral body. This, in turn, created the need for instrumented stabilization of the lower cervical spine: a C6–T1 fixation. Because there has been no local recurrence at the 6-year follow-up visit, we conclude that the surgical resection was curative. Moreover, because there has been no other manifestation of carcinoid tumor in this patient, it is probable that the cervical involvement was primary, not a metastasis from common sites, such as the gastrointestinal tract or bronchi.
Primary cervical carcinoid tumor is a rare entity, but should be included in the differential diagnosis of enhancing expansile extradural masses compressing the spinal cord and nerves. Surgical intervention should aim at gross total resection, because it may provide a definitive cure. Spinal instrumentation may be needed to provide stability following tumor resection.
Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
- Buchanan KD, Johnston CF, O'Hare MM, Ardill JE, Shaw C, Collins JS, Watson RG, Atkinson AB, Hadden DR, Kennedy TL, Sloan JM: Neuroendocrine tumors. A European view. Am J Med. 1986, 81: 14-22. 10.1016/0002-9343(86)90581-4.View ArticlePubMedGoogle Scholar
- Modlin IM, Lye KD, Kidd M: A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003, 97: 934-959. 10.1002/cncr.11105.View ArticlePubMedGoogle Scholar
- Patchell RA, Posner JB: Neurologic complications of carcinoid. Neurology. 1986, 36: 745-749. 10.1212/WNL.36.6.745.View ArticlePubMedGoogle Scholar
- Gowitt GT, Mirra SS: Malignant carcinoid causing spinal cord compression. Neurosurgery. 1985, 17: 801-806. 10.1227/00006123-198511000-00013.View ArticlePubMedGoogle Scholar
- Cianfoni A, Distefano D, Chin SH, Varma AK, Rumboldt Z, Bonaldi G: Percutaneous cement augmentation of a lytic lesion of C1 via posterolateral approach under CT guidance. Spine J. 2012, 12: 500-506. 10.1016/j.spinee.2012.05.012.View ArticlePubMedGoogle Scholar
- Kirkpatrick DB, Dawson E, Haskell CM, Batzdorf U: Metastatic carcinoid presenting as a spinal tumor. Surg Neurol. 1975, 4: 283-287.PubMedGoogle Scholar
- Poole CJ: Myelopathy secondary to metastatic carcinoid tumour. J Neurol Neurosurg Psychiatry. 1984, 47: 1359-1360. 10.1136/jnnp.47.12.1359.View ArticlePubMedPubMed CentralGoogle Scholar
- Tanabe M, Akatsuka K, Umeda S, Shomori K, Taniura S, Okamoto H, Kamitani H, Watanabe T: Metastasis of carcinoid to the arch of the axis in a multiple endocrine neoplasia patient: a case report. Spine J. 2008, 8: 841-844. 10.1016/j.spinee.2007.06.015.View ArticlePubMedGoogle Scholar
- Zuetenhorst JM, Taal BG: Metastatic carcinoid tumors: a clinical review. Oncologist. 2005, 10: 123-131. 10.1634/theoncologist.10-2-123.View ArticlePubMedGoogle Scholar
- Dujardin F, Beaussart P, de Muret A, Rosset P, Waynberger E, Mulleman D, de Pinieux G: Primary neuroendocrine tumor of the sacrum: case report and review of the literature. Skeletal Radiol. 2009, 38: 819-823. 10.1007/s00256-009-0693-y.View ArticlePubMedGoogle Scholar
- Schnee CL, Hurst RW, Curtis MT, Friedman ED: Carcinoid tumor of the sacrum: case report. Neurosurgery. 1994, 35: 1163-1167. 10.1227/00006123-199412000-00024.View ArticlePubMedGoogle Scholar
- Krasin E, Nirkin A, Issakov J, Rabau M, Meller I: Carcinoid tumor of the coccyx: case report and review of the literature. Spine (Phila Pa 1976). 2001, 26: 2165-2167. 10.1097/00007632-200110010-00025.View ArticleGoogle Scholar
- Gray JA, Nishikawa H, Jamous MA, Grahame-Smith DG: Spinal cord compression due to carcinoid metastasis. Postgrad Med J. 1988, 64: 703-705. 10.1136/pgmj.64.755.703.View ArticlePubMedPubMed CentralGoogle Scholar
- Nathoo N, Mendel E: Spinal carcinoid metastasis: rare but important differential diagnosis of a spinal mass. World Neurosurg. 2011, 76: 415-416. 10.1016/j.wneu.2010.11.023.View ArticlePubMedGoogle Scholar
- Rao KC, Jhaveri HS, Gellad FE: Carcinoid tumor with intradural spinal metastases. J Comput Tomogr. 1988, 12: 258-260. 10.1016/0149-936X(88)90080-X.View ArticlePubMedGoogle Scholar
- Travis WD, Linnoila RI, Tsokos MG, Hitchcock CL, Cutler GB, Nieman L, Chrousos G, Pass H, Doppman J: Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases. Am J Surg Pathol. 1991, 15: 529-553. 10.1097/00000478-199106000-00003.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.